A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency is a research paper published in PLoS Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Dental and Craniofacial Research
Grant: R01DE025565
National Institute of General Medical Sciences
Grant: P20GM134974
Feist-Weiller Cancer Center
Grant: Carroll Feist predoctoral fellowship
LSU Center for Emerging Viral Threts
Grant: predoctoral fellowship
NIAID NIH HHS
Grant: P01 AI127335
National Institutes of Health
Grant: 5R01DE025565-03
Epigenetic Effects of Epstein-Barr Virus Infection in Oral Squamous Cell Carcinoma
National Institutes of Health
Grant: 1P20GM134974-01A1
Center for Applied Immunology and Pathological Processes
FWCI
1.26
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency